Abstract:Despite recent advances in cancer treatment, metastasis is the cause of mortality in 90% of cancer cases. It has now been well-established that dissemination of cancer cells to distant sites occurs very early during tumorigenesis, resulting in the minimal effect of surgical or chemotherapeutic treatments after the detection of metastasis. The underlying reason for this challenge is mostly due to the limited understanding of molecular mechanisms of the metastasis cascade, particularly related to metastatic traits. Therefore, there is an urgent need to investigate this currently invisible evolution of metastasis. The tracking of metastasis evolution has not been addressed yet. Here, we introduce, for the first time, a synchronous approach to unveil the molecular mechanisms of the metastasis cascade. As cancer stem cells (CSCs) demonstrate cancer initiation, drug resistance, metastasis, and tumor relapse and can exist in a quasi-intermediate epithelial-mesenchymal transition state, the tumor-initiating events during a CSCs metamorphosis were monitored with single-cell sensitivity. Because of the invasive and resistive properties of the metastable intermediate CSCs, investigation of the molecular profiles of the quasi-intermediate CSCs was necessary for the detection of metastasis dissemination. For this purpose, the ultrasensitive technique of surface-enhanced Raman scattering (SERS) was adopted. Titanium-based, biocompatible three-dimensional (3D) nanoprobes that were synthesized for multiphoton ionization achieved a substantial SERS enhancement of ∼80-fold due to the oxygen vacancy-enriched composition of the nanoprobes. The 3D interconnected complex nanoarchitecture of the nanoprobes enabled us to entrap the nonadherent CSCs of three metastatic cancer cell lines (triple negative breast adenocarcinoma (MDAMB231), human Caucasian colon adenocarcinoma (COLO 205), and cervical adenocarcinoma (HeLa)─all very aggressive forms of cancer). The nanoprobes not only promoted the CSC proliferation to successfully attain the quasi-intermediate states but also monitored its reprogramming into a cancer cell state. The nanoprobes substantially amplified weak intracellular Raman signals to capture the molecular events during a CSC transformation. The detection of cancer was achieved with 100% accuracy. We experimentally demonstrated that the molecular signatures of CSC reprogramming are cancer-type specific. This observation enabled us to identify the origin of metastasis with 100% accuracy, providing more clarity on the relatively unknown quasi-intermediate states. This first demonstration of CSC-based tracking of metastasis evolution has the potential to provide an insightful perspective of tumorigenesis that could be useful in cancer diagnosis and prognosis as well as in the monitoring of therapeutic interventions.

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model

Metastasis-on-a-chip Mimicking the Progression of Kidney Cancer in the Liver for Predicting Treatment Efficacy

Development of a cancer metastasis-on-chip assay for high throughput drug screening

Development of a Microphysiological System to Model Human Cancer Metastasis From the Colon to the Liver

A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model

Quantitative Analysis of Human Cancer Cell Extravasation Using Intravital Imaging

A Novel Method for the Early Detection of Single Circulating, Metastatic and Self-Seeding Cancer Cells in Orthotopic Breast Cancer Mouse Models

Assessing the metastatic potential of circulating tumor cells using an organ-on-chip model

Two channel compartmentalized microfluidic chip for real time monitoring of the metastatic cascade

Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish.

Real Time Metastatic Route Tracking of Orthotopic PC‐3‐GFP Human Prostate Cancer Using Intravital Imaging

A high-throughput microfabricated platform for rapid quantification of metastatic potential

Abstract IA23: Single cell-resolution lineage tracing of tumors in a mouse xenograft model reveals rapid and multidirectional metastasis

Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model

Mimicking Tumor Metastasis Using a Transwell-Integrated Organoids-On-a-Chip Platform

Mesenchymal-mode Migration Assay and Antimetastatic Drug Screening with High-Throughput Microfluidic Channel Networks.

In vivo interaction screening reveals liver-derived constraints to metastasis

Tracking the Evolution of Metastasis with Self-Functionalized 3D Nanoprobes

A Novel Microfluidic Model Can Mimic Organ-Specific Metastasis of Circulating Tumor Cells

Detection of Circulating Tumor Cells Using Antibody-Functionalized Microchips to Monitor Tumorigenesis in a Mouse Model of Metastatic Breast Cancer

Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies